M
Michael D. Smith
Researcher at Goddard Space Flight Center
Publications - 449
Citations - 25323
Michael D. Smith is an academic researcher from Goddard Space Flight Center. The author has contributed to research in topics: Mars Exploration Program & Atmosphere of Mars. The author has an hindex of 85, co-authored 420 publications receiving 23108 citations. Previous affiliations of Michael D. Smith include Harvard University & University of Toronto.
Papers
More filters
Journal ArticleDOI
Background levels of methane in Mars' atmosphere show strong seasonal variations
Christopher R. Webster,Paul R. Mahaffy,Sushil K. Atreya,John E. Moores,G. Flesch,Charles Malespin,Christopher P. McKay,German Martinez,Christina L. Smith,Javier Martin-Torres,Javier Martin-Torres,Javier Gómez-Elvira,María Paz Zorzano,María Paz Zorzano,Michael H. Wong,Melissa G. Trainer,Andrew Steele,P. Douglas Archer,Brad Sutter,Patrice Coll,Caroline Freissinet,Pierre-Yves Meslin,Raina V. Gough,Christopher H. House,Alexander A. Pavlov,Jennifer L. Eigenbrode,Daniel P. Glavin,John C. Pearson,Didier Keymeulen,Lance E. Christensen,Susanne P. Schwenzer,Rafael Navarro-González,Jorge Pla-Garcia,Jorge Pla-Garcia,Scot Rafkin,Álvaro Vicente-Retortillo,Henrik Kahanpää,Daniel Viúdez-Moreiras,Michael D. Smith,Ari-Matti Harri,Maria Genzer,Donald M. Hassler,Mark T. Lemmon,Joy A. Crisp,Stanley P. Sander,Richard W. Zurek,Ashwin R. Vasavada +46 more
TL;DR: In situ measurements at Gale crater made over a 5-year period by the Tunable Laser Spectrometer on the Curiosity rover show large seasonal variation in the background and occurrences of higher temporary spikes that are consistent with small localized sources of methane released from martian surface or subsurface reservoirs.
Journal ArticleDOI
Constraints on dust aerosols from the Mars Exploration Rovers using MGS overflights and Mini‐TES
Michael J. Wolff,Michael D. Smith,R. T. Clancy,N. Spanovich,Barbara A. Whitney,Mark T. Lemmon,Joshua L. Bandfield,Don Banfield,A. Ghosh,G. Landis,Philip R. Christensen,James F. Bell,Steven W. Squyres +12 more
TL;DR: In this paper, the authors used the results of the Mars Global Surveyor (MGS) and the Mars Exploration Rovers (MER) data to obtain the set of refractive indices in the infrared and applied them to a larger sample of Mini-TES data.
Journal ArticleDOI
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation.
Andrés Jaramillo,Michael D. Smith,Donna Phelan,Sudhir Sundaresan,Elbert P. Trulock,John Lynch,Joel D. Cooper,G.A. Patterson,T. Mohanakumar +8 more
TL;DR: Monitoring of anti-HLA class I antibody development by a highly sensitive assay such as the PRA-STAT ELISA after LT can provide an early identification of an important subset of LT patients with an increased risk of developing BOS.
Journal ArticleDOI
Clinical Policy: Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department
Michael D. Brown,Richard L. Byyny,Deborah B. Diercks,Seth R. Gemme,Charles J. Gerardo,Steven A. Godwin,Sigrid A. Hahn,Benjamin W. Hatten,Jason S. Haukoos,Graham S. Ingalsbe,Amy H. Kaji,Heemun Kwok,Bruce M. Lo,Sharon E. Mace,Devorah J. Nazarian,Jean A. Proehl,Susan B. Promes,Kaushal Shah,Richard D. Shih,Scott M. Silvers,Michael D. Smith,Molly E.W. Thiessen,Christian Tomaszewski,Jonathan H. Valente,Stephen P. Wall,Stephen J. Wolf,Stephen V. Cantrill,Robert E. O'Connor,Jon Mark Hirshon,Rhonda R. Whitson,Joshua S. Broder,Michael P. Wilson,Leslie S. Zun +32 more
TL;DR: From the American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department.
Journal ArticleDOI
Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Mark T. Brown,Frederick T. Murphy,David M. Radin,Isabelle Davignon,Michael D. Smith,Christine R. West +5 more
TL;DR: This is the first phase III randomized, controlled trial to demonstrate that nerve growth factor blockade by tanezumab has superior analgesic efficacy in OA of the knee compared with placebo.